Literature DB >> 12401859

Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction.

Chérif Badid1, Alexis Desmouliere, Daniela Babici, Aoumeur Hadj-Aissa, Brigitte McGregor, Nicole Lefrancois, Jean Louis Touraine, Maurice Laville.   

Abstract

BACKGROUND: Renal myofibroblast infiltration has been shown to be strongly associated with renal function decline in several chronic renal diseases. The purpose of the present study was to investigate whether early detection of myofibroblast infiltration using alpha-smooth-muscle actin (alpha-SMA) expression in time-zero biopsies predicts renal allograft dysfunction.
METHODS: We studied renal tissue from 38 renal transplant patients from whom biopsies had been taken after vascular anastomosis during transplantation to ascertain whether myofibroblasts infiltration predicts renal graft survival. Immunohistochemistry was performed on time-zero biopsies to determine alpha-SMA expression, and this was compared to annual glomerular filtration rate (GFR) variation and other parameters including cold ischaemic time (CIT), donor and recipient age, number of acute rejections, and delayed graft function (DGF). GFR was measured by inulin clearance during of 3 years of follow-up after the transplantation. Progressors were defined as patients with an annual GFR decline >5 ml/min/year.
RESULTS: We found a significant correlation between interstitial alpha-SMA expression in time-zero biopsies and GFR evolution during the post-transplantation course (r=0.60, P<0.001). Although progressors had greater interstitial alpha-SMA expression than non progressors (7.9+/-0.7 vs 4.3+/-0.4%), they showed only a tendency towards higher glomerular alpha-SMA expression. In addition, progressors had more interstitial fibrosis in time-zero biopsies than non-progressors. There was no relationship between alpha-SMA expression and CIT, donor and recipient ages, number of acute rejections, and occurrence of DGF.
CONCLUSION: This study suggests that alpha-SMA evaluation in time-zero biopsies, especially the combination of alpha-SMA expression and interstitial fibrosis, can strongly predict chronic renal allograft dysfunctions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401859     DOI: 10.1093/ndt/17.11.1993

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  21 in total

1.  Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.

Authors:  Qingjuan Liu; Lingling Xing; Lei Wang; Fang Yao; Shuxia Liu; Jun Hao; Wei Liu; Huijun Duan
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

Review 2.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

3.  MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.

Authors:  Hui Tang; Di Fan; Chun-Tao Lei; Chen Ye; Pan Gao; Shan Chen; Xian-Fang Meng; Hua Su; Chun Zhang
Journal:  J Mol Med (Berl)       Date:  2016-08-03       Impact factor: 4.599

4.  TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture.

Authors:  Monica Forino; Rossella Torregrossa; Monica Ceol; Luisa Murer; Manuela Della Vella; Dorella Del Prete; Angela D'Angelo; Franca Anglani
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

5.  Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice.

Authors:  Yanqiu Wang; Bowen Wang; Feng Du; Xuesong Su; Guangping Sun; Guangyu Zhou; Xiaohui Bian; Na Liu
Journal:  J Histochem Cytochem       Date:  2014-12-30       Impact factor: 2.479

6.  Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.

Authors:  Ying-Ying Wang; Hong Jiang; Jun Pan; Xiao-Ru Huang; Yu-Cheng Wang; Hong-Feng Huang; Ka-Fai To; David J Nikolic-Paterson; Hui-Yao Lan; Jiang-Hua Chen
Journal:  J Am Soc Nephrol       Date:  2017-02-16       Impact factor: 10.121

7.  CFTR dysfunction predisposes to fibrotic liver disease in a murine model.

Authors:  Camilia R Martin; Munir M Zaman; Gyanprakash A Ketwaroo; Abdul Q Bhutta; Emmanuel Coronel; Yury Popov; Detlef Schuppan; Steven D Freedman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-07       Impact factor: 4.052

8.  Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis.

Authors:  Carla Q Feitoza; Giselle M Gonçalves; Patrícia Semedo; Marcos A Cenedeze; Hélady S Pinheiro; Felipe Caetano Beraldo; Oscar Fernando Pavão dos Santos; Vicente de Paula A Teixeira; Marlene A dos Reis; Marilda Mazzali; Alvaro Pacheco-Silva; Niels O S Câmara
Journal:  Mol Med       Date:  2008-08-18       Impact factor: 6.354

9.  Ischemia induces early expression of a new transcription factor (6A3-5) in kidney vascular smooth muscle cells: studies in rat and human renal pathology.

Authors:  Gwenaële Garin; Chérif Badid; Brigitte McGregor; Madeleine Vincent; Sylviane Guerret; Kazem Zibara; Adam Hurlstone; Maurice Laville; John L McGregor
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 10.  The role of pericyte detachment in vascular rarefaction.

Authors:  Claudia Schrimpf; Omke E Teebken; Mathias Wilhelmi; Jeremy S Duffield
Journal:  J Vasc Res       Date:  2014-09-03       Impact factor: 1.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.